Per ulteriori informazioni selezionare i riferimenti di interesse.
Studies on [H-3]CP-55940 binding in the human central nervous system: Regional specific changes in density of cannabinoid-1 receptors associated withschizophrenia and cannabis use
NEUROSCIENCE
Basic and clinical science of substance related disorders
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
PLATELET [H-3]DOPAMINE UPTAKE IS DIFFERENTIALLY AFFECTED BY NEUROLEPTIC DRUG-TREATMENT IN SCHIZOPHRENIA AND SCHIZOPHRENIFORM DISORDER
Progress in neuro-psychopharmacology & biological psychiatry
TYPICAL AND ATYPICAL NEUROLEPTIC DRUGS DECREASE PLATELET H-3 DOPAMINEUPTAKE IN THE RAT
Psychiatry research
DOPAMINE UPTAKE IN PLATELETS - RESPONSE
Biological psychiatry
THE EFFECT OF NEUROLEPTIC TREATMENT ON DOPAMINE UPTAKE BY PLATELETS FROM SUBJECTS WITH PSYCHOSIS
Schizophrenia research
THE DEVELOPMENT OF A METHOD TO MEASURE [H-3] DOPAMINE UPTAKE BY WASHED PLATELETS PROVIDES NO EVIDENCE FOR CIRCULATING INHIBITORS OF PLATELET DOPAMINE UPTAKE IN SCHIZOPHRENIA
Biological psychiatry